Biotechnology

MOLECULAR TEMPLATES INC

Molecular Templates Inc. released FY2024 Semi-Annual Earnings on August 14 (EST), actual revenue USD 11.66 M, actual EPS USD -1.2613

Molecular Templates Inc. released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 572 K (forecast USD 6.13 M), actual EPS USD -1.2348

MTEMQ.US released FY2023 Semi-Annual earnings on August 14 (BJT), actual revenue USD 43.49 M, actual EPS USD -0.0061

Molecular Templates Inc. released FY2023 Q2 earnings on August 14 (EST), actual revenue USD 6.865 M (forecast USD 2.575 M), actual EPS USD -2.8929

Molecular Templates Inc. released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 11.09 M (forecast USD 5.897 M), actual EPS USD 0.0799

MTEMQ.US released FY2023 Q1 earnings on May 15 (BJT), actual revenue USD 36.63 M (forecast USD 2.25 M), actual EPS USD 2.8868

Molecular Templates Inc. released FY2022 Q4 earnings on March 29 (EST), actual revenue USD 2.611 M (forecast USD 8.811 M), actual EPS USD -5.8691

Molecular Templates Inc. released FY2022 earnings on March 29 (EST), actual revenue USD 19.75 M (forecast USD 25.94 M), actual EPS USD -24.6881

Molecular Templates Inc. released FY2023 earnings on March 29 (EST), actual revenue USD 57.31 M (forecast USD 58.07 M), actual EPS USD -1.8048

MTEMQ.US released FY2023 Q4 earnings on March 29 (BJT), actual revenue USD 7.016 M (forecast USD 7.775 M), actual EPS USD -0.7346

Treasure Gbl

SMX Security Matters

Wheeler Real Estate

Gulf Resources

DigitalBridge

Toro

Dreamland

Lichen

Springview

Alumis

Adma Biologics

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel Pharma

OpGen

Vertex Pharma

Regeneron Pharma

Alnylam Pharma

Argenx

Beigene

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap